Menu Search
Investment Trusts

The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)966.00
  • Today's Change-28.00 / -2.82%
  • Shares traded51.78k
  • 1 Year change-18.27%
  • Beta0.8275
Data delayed at least 20 minutes, as of Aug 17 2022 16:35 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Total returns on £1000

1Y
Fund/benchmarkChange
PriceThe Biotech Growth Trust PLC (Ordinary Share)-14.22%
NAVThe Biotech Growth Trust PLC (Ordinary Share)-14.02%
Morningstar's BenchmarkNASDAQ Biotechnology TR GBP--
--

Key statistics

On Wednesday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 966.00, 33.73% above the 52 week low of 722.37 set on May 12, 2022.
52-week range
Today
722.37May 12 20221,278.00Sep 08 2021
Markit short selling activity
Low
Med
High
Shares outstanding40.87m
Market cap404.68m GBP
Total assets485.91m GBP
Total expense ratio1.06%
High1,000.00
Low966.00
Previous close966.00
Average volume99.00k
YTD Change-18.69%
Beta0.8275
Diluted NAV (est)1,071.58
Diluted NAV (last pub)1,072.86
Premium/Discount-9.85%
Net Gearing+7.77%
Data delayed at least 20 minutes, as of Aug 17 2022 16:35 BST.
More ▼

Annual Reports

Board of Directors

1/7

Andrew Joy, Independent Non-Executive Chairman

2/7

Geoff Hsu, Non-Executive Director

3/7

Steve Bates, Independent Non-Executive Director

4/7

Lord Willetts, Independent Non-Executive Director

5/7

Julia Le Blan, Independent Non-Executive Director

6/7

Dr Nicola Shepherd, Independent Non-Executive Director

7/7

Roger Yates

Further Information

Contact

The Biotech Growth Trust PLC:
25 Southampton Buildings
London
WC2A 1AL

T: 0203 008 4910
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.